Thanks for visiting Research Information.

You're trying to access an editorial feature that is only available to logged in, registered users of Research Information. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

F1000 appoints Rebecca Lawrence as managing director

Share this on social media:

F1000, a provider of services to biomedical researchers to support the discovery, writing and publication of new scientific findings, has announced the appointment of Rebecca Lawrence as managing director. Lawrence was previously managing director of F1000 Research Ltd, the publishing arm of F1000.

During the six years she has worked at F1000, Lawrence has launched and established both F1000Research (the open science publishing platform) and F1000Posters (the open access repository of posters and slides, now incorporated into F1000Research). She has more than 15 years’ experience in the STM publishing industry, is also co-Chair of several international initiatives around peer review recognition and data sharing, working with ORCID, CASRAI, RDA, BioSharing and other major organisations.

F1000 says the appointment marks an important transition in moving towards an integrated suite of products overseen by the F1000 Faculty, a unique and prestigious group of over 11,000 experts across biology and medicine.

Vitek Tracz, Chairman & CEO, F1000, said: 'Rebecca Lawrence has shown a clear grasp of the issues we address and demonstrated an outstanding ability to change these into practical and useful services. I am confident she will play a central role in creating the new environment that researchers need science publishers to develop.'  

Lawrence added: 'I am delighted to take on this new role at F1000 and am looking forward to the challenges ahead.  F1000 is in a truly unique position to help make a sea-change in how new findings are shared, researchers are evaluated, and ultimately in how the whole scientific enterprise functions, for the good of science and ultimately for healthcare.

'There now seems to be a palpable desire, amongst both scientists and those involved in policy, to change the system that is getting increasingly skewed and biased by the current publishing and evaluation system.  I feel incredibly privileged to be able to play an important role in this transformative journey.'